Kratz Lab Publications
Kratz Lab Publications
- P1.07.40 Detection of ctDNA Prior to Neoadjuvant Osimertinib Treatment Correlates With Decreased EFS in EGFR-Mutated NSCLC.
2025 | UCSF Research Profile - Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
2024 |
PubMed
- An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay.
2025 | UCSF Research Profile - 8P Precision medicine drug testing platform to guide the treatment of EML4-ALK fusion lung cancers.
2024 | UCSF Research Profile - Never Fear, the Robot Is Here: Robotic Resection for a Giant Thymoma.
2025 |PubMed
- Letter: Commentary: Trans-Sternal Multilevel Corpectomy for Cervicothoracic Renal Cell Metastasis: 2-Dimensional Operative Video.
2024 |PubMed
- Outpatient opioid use after minimally invasive surgery for lung cancer: a Surveillance, Epidemiology, and End Results-Medicare cohort study.
2025 |PubMed
- Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.
2024 | UCSF Research Profile - Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
2025 |PubMed
- Abstract C025: Identification of cell-cell signaling programs across the tumor-tumor microenvironment ecosystem and associated with clinical status in neoadjuvant osimertinib treated patient samples revealed by spatial profiling.
2024 | UCSF Research Profile